Positive.

From Yahoo Finance: 2025-04-21 12:42:00

Quest Diagnostics Incorporated (DGX) is a compelling investment opportunity, trading at $163.80 with a market cap of $18.18 billion. The company provides diagnostic information services globally, with a forward dividend yield of around 2%. Quest’s growth is driven by advancements in digitalization and robotics, along with increasing demand for diagnostic testing due to aging populations and chronic diseases. The company’s disciplined acquisition strategy has expanded its footprint, with a fair value estimate of $180 per share. Quest Diagnostics presents an attractive investment opportunity for stability and growth in an uncertain market.



Read more at Yahoo Finance: Quest Diagnostics Incorporated (DGX): A Bull Case Theory